Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines

M Schaefer, S Hagemann, K Hanna, F Lyko - Cancer research, 2009 - AACR
The cytosine analogues azacytidine and decitabine are currently being developed as drugs
for epigenetic cancer therapy. Although various studies have shown that both drugs are …

Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications

V Santini, HM Kantarjian, JP Issa - Annals of internal medicine, 2001 - acpjournals.org
Methylation of DNA is a biochemical modification that can influence gene expression and is
involved in inactivating one of the two X chromosomes in women. Evidence that has …

Methylation of DNA in cancer

Y Watanabe, M Maekawa - Advances in clinical chemistry, 2010 - Elsevier
Epigenetic mechanisms are essential for normal development and maintenance of tissue-
specific gene expression patterns in mammals. Disruption of epigenetic processes can lead …

Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells

S Valente, Y Liu, M Schnekenburger… - Journal of medicinal …, 2014 - ACS Publications
DNA methyltransferases (DNMTs) are important enzymes involved in epigenetic control of
gene expression and represent valuable targets in cancer chemotherapy. A number of …

Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells

M Billam, MD Sobolewski, NE Davidson - Breast cancer research and …, 2010 - Springer
Because DNA methyltransferase (DNMT) inhibitors like azacytidine and decitabine are
known to be effective in the clinic for diseases like myelodysplastic syndromes that may …

Targeting DNA methylation for epigenetic therapy

X Yang, F Lay, H Han, PA Jones - Trends in pharmacological sciences, 2010 - cell.com
Patterns of DNA methylation are established during embryonic development and faithfully
copied through somatic cell divisions. Based on current understanding of DNA methylation …

DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy

J Worm, P Guldberg - Journal of oral pathology & medicine, 2002 - Wiley Online Library
The unique properties of a cancer cell are acquired through a stepwise accumulation of
heritable changes in the information content of proto‐oncogenes and tumor suppressor …

DNA methyltransferase inhibitors: catalysts for antitumour immune responses

H Dan, S Zhang, Y Zhou, Q Guan - OncoTargets and therapy, 2019 - Taylor & Francis
Epigenetics is a kind of heritable change that involves the unaltered DNA sequence and can
have effects on gene expression. The regulatory mechanism mainly includes DNA …

Multitarget drugs: an epigenetic epiphany

A Ganesan - ChemMedChem, 2016 - Wiley Online Library
Epigenetics refers to changes in a biological phenotype that are not due to an underlying
change in genotype. In eukaryotes, epigenetics involves a set of chemical modifications of …

DNA methylation: an alternative pathway to cancer

SA Wajed, PW Laird, TR DeMeester - Annals of surgery, 2001 - journals.lww.com
Objective To provide an introduction to the concept of DNA methylation and its function in
normal cells, and to explain the possible mechanisms as to how abnormalities in this …